Investor Lincoln Park Capital Fund, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Lincoln Park Capital Fund, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-02-14 13G/A US49721T1016 / KIORA PHARMACEUTICALS INC 3,280,476 768,155
2024-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 1,810,087 1,600,136
2024-02-14 13G/A ENSC / Ensysce Biosciences, Inc. 1,501,055 124,008
2024-02-14 13G/A TCON / TRACON Pharmaceuticals, Inc. 2,369,821 116,821
2024-02-14 13G/A CLRB / Cellectar Biosciences, Inc. 937,588 1,307,049
2024-02-14 13G/A WINT / Windtree Therapeutics, Inc. 459,042 339,167
2023-06-02 13G TCON / TRACON Pharmaceuticals, Inc. 2,369,821
2023-04-24 13G WINT / Windtree Therapeutics, Inc. 459,042
2023-02-07 13G ENSC / Ensysce Biosciences, Inc. 1,501,055 1,501,055
2022-10-25 13G CLRB / Cellectar Biosciences, Inc. 2,313,683 937,588
2022-07-28 13G US49721T1016 / KIORA PHARMACEUTICALS INC 3,280,476
2022-05-18 13G VLON / Vallon Pharmaceuticals Inc 1,050,232
2022-04-27 13G SLRX / Salarius Pharmaceuticals, Inc. 2,969,718
2022-01-19 13G XFOR / X4 Pharmaceuticals, Inc. 1,810,087
2021-11-19 13G NBRV / Nabriva Therapeutics Plc 4,512,589
2021-04-28 13G BNTC / Benitec Biopharma Inc. 423,529
2021-01-19 13G VIVE / Viveve Medical, Inc. 701,000 701,000
2021-01-19 13G VIVE / Viveve Medical, Inc. 701,000 701,000
2021-01-08 13G ONTX / Onconova Therapeutics, Inc. 13,639,411
2020-11-13 13G MBRX / Moleculin Biotech, Inc. 4,787,254
2020-08-03 13G ADXS / Ayala Pharmaceuticals, Inc. 4,594,793
2020-07-13 13G CLRB / Cellectar Biosciences, Inc. 2,313,683
2020-03-02 13G CLSN / Imunon Inc 1,581,429
2020-02-27 13G BBI / Brickell Biotech Inc 965,723
2020-01-29 13G VTGN / Vistagen Therapeutics, Inc. 4,614,602
2019-11-04 13G TROV / TrovaGene, Inc. 798,121 798,121
2019-11-01 13G TROV / TrovaGene, Inc. 798,121
2019-06-07 13G WWR / Westwater Resources, Inc. 104,294
2018-09-24 13G BIOC / Biocept Inc 394,263
2018-04-13 13G PHIO / Phio Pharmaceuticals Corp. 428,638 428,638
2018-04-12 13G PHIO / Phio Pharmaceuticals Corp. 428,638